{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:18:36Z","timestamp":1761513516594,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.clbc.2016.07.011","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T07:38:43Z","timestamp":1469777923000},"page":"117-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Lymph Node Ratio in Sentinel Lymph Node Biopsy Era: Are We Losing Prognostic Information?"],"prefix":"10.1016","volume":"17","author":[{"given":"Keith Ian","family":"Quintyne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernie","family":"Woulfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Coffey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Merrigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajnish K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2016.07.011_bib1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10549-011-1730-9","article-title":"Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society","volume":"130","author":"Ahn","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2016.07.011_bib2","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1245\/s10434-011-2012-9","article-title":"Lymph node ratio should be considered for incorporation into staging for breast cancer","volume":"18","author":"Chagpar","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2016.07.011_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jamcollsurg.2011.04.024","article-title":"Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients","volume":"213","author":"Schiffman","year":"2011","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.clbc.2016.07.011_bib4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial","volume":"252","author":"Giuliano","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2016.07.011_bib5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2016.07.011_bib6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.6004\/jnccn.2013.0098","article-title":"Breast cancer, version 3.2013: featured updates to the NCCN guidelines","volume":"11","author":"Theriault","year":"2013","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.clbc.2016.07.011_bib7","doi-asserted-by":"crossref","first-page":"v8","DOI":"10.1093\/annonc\/mdv298","article-title":"Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Senkus","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2016.07.011_bib8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.clbc.2012.07.009","article-title":"Lymph node ratio and pN staging show different superiority as prognostic predictors depending on the number of lymph nodes dissected in Chinese patients with luminal A breast cancer","volume":"12","author":"Wang","year":"2012","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2016.07.011_bib9","first-page":"765","article-title":"The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast","volume":"152","author":"Fisher","year":"1981","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.clbc.2016.07.011_bib10","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jamcollsurg.2010.02.045","article-title":"Improved staging in node-positive breast cancer patients using lymph node ratio: results in 1,788 patients with long-term follow-up","volume":"210","author":"Danko","year":"2010","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.clbc.2016.07.011_bib11","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1245\/s10434-010-0954-y","article-title":"Micrometastatic node-positive breast cancer: long-term outcomes and identification of high-risk subsets in a large population-based series","volume":"17","author":"Truong","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2016.07.011_bib12","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1634\/theoncologist.2010-0044","article-title":"Age and axillary lymph node ratio in postmenopausal women with T1-T2 node positive breast cancer","volume":"15","author":"Vinh-Hung","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.clbc.2016.07.011_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s40064-015-0865-2","article-title":"Prognostic value of the lymph node ratio for lymph-node-positive breast cancer\u2014is it just a denominator problem?","volume":"4","author":"Jayasinghe","year":"2015","journal-title":"Springerplus"},{"key":"10.1016\/j.clbc.2016.07.011_bib14","doi-asserted-by":"crossref","first-page":"8706","DOI":"10.1200\/JCO.2005.02.8852","article-title":"Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes","volume":"23","author":"Berger","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2016.07.011_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10151-011-0701-9","article-title":"Metastatic lymph node ratio (LNR) as a prognostic variable in colorectal cancer patients undergoing laparoscopic resection","volume":"15","author":"Greenberg","year":"2011","journal-title":"Tech Coloproctol"},{"key":"10.1016\/j.clbc.2016.07.011_bib16","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1245\/s10434-011-1687-2","article-title":"Can lymph node ratio take the place of pN categories in the UICC\/AJCC TNM classification system for colorectal cancer?","volume":"18","author":"Tong","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2016.07.011_bib17","first-page":"19","article-title":"Proposal of new nodal classifications for non-small-cell lung cancer based on the number and ratio of metastatic lymph nodes","volume":"41","author":"Matsuguma","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.clbc.2016.07.011_bib18","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00384-013-1707-8","article-title":"An appraisal of lymph node ratio in colon and rectal cancer: not one size fits all","volume":"28","author":"Medani","year":"2013","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.clbc.2016.07.011_bib19","article-title":"Neoadjuvant therapy does not affect lymph node ratio in rectal cancer","author":"Chang","year":"2015","journal-title":"Surgeon"},{"key":"10.1016\/j.clbc.2016.07.011_bib20","doi-asserted-by":"crossref","first-page":"b375","DOI":"10.1136\/bmj.b375","article-title":"Prognosis and prognostic research: what, why, and how?","volume":"338","author":"Moons","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.clbc.2016.07.011_bib21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjc.6602678","article-title":"REporting recommendations for tumour MARKer prognostic studies (REMARK)","volume":"93","author":"McShane","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2016.07.011_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.7326\/0003-4819-144-3-200602070-00009","article-title":"Translating clinical research into clinical practice: impact of using prediction rules to make decisions","volume":"144","author":"Reilly","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clbc.2016.07.011_bib23","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1245\/ASO.2003.03.073","article-title":"Breast cancer survival according to number of nodes removed","volume":"10","author":"Krag","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2016.07.011_bib24","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1245\/ASO.2003.10.917","article-title":"The eternally enigmatic axilla: further controversy about axillary lymph nodes in breast cancer","volume":"10","author":"McMasters","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2016.07.011_bib25","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1200\/JCO.2005.03.1526","article-title":"Prognostic value of nodal ratios in node-positive breast cancer","volume":"24","author":"Woodward","year":"2006","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152682091630204X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152682091630204X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:14:53Z","timestamp":1761513293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152682091630204X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S152682091630204X"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2016.07.011","relation":{},"ISSN":["1526-8209"],"issn-type":[{"type":"print","value":"1526-8209"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymph Node Ratio in Sentinel Lymph Node Biopsy Era: Are We Losing Prognostic Information?","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2016.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}